Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

8.72
Delayed Data
As of Oct 30
 -0.02 / -0.23%
Today’s Change
6.25
Today|||52-Week Range
13.76
-11.02%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$9.6B

Company Description

Teva Pharmaceutical Industries Ltd. engages in the development and production of medicines. Its products include medicines for cardiovascular diseases, pain relievers, obesity, cancer and supportive care, infectious diseases and human immunodeficiency viruses, and colds and coughs. The company was founded in 1901 and is headquartered in Petah Tikva, Israel.

Contact Information

Teva Pharmaceutical Industries Ltd.
5 Basel Street
Petach Tikva Hamerkaz 4951033
P:(723) 926-7267
Investor Relations:
(723) 926-7516

Employees

Shareholders

Other institutional27.83%
Mutual fund holders25.24%
Individual stakeholders0.14%

Top Executives

Kåre SchultzPresident, Chief Executive Officer & Director
Eric DrapéExecutive Vice President-Global Operations
Eli KalifChief Financial Officer & Executive Vice President
David M. StarkChief Legal Officer & Executive Vice President
Nir BaronChief Internal Auditor & Executive Vice President